Pathway for Evaluation and Treatment of Child with Community-Acquired Pneumonia
Child with Suspected Community Acquired Pneumonia
This pathway is to be used for healthy children > 56 days through 18 years of age with suspected/proven community-acquired pneumonia managed in the outpatient, Emergency Department, inpatient, or intensive care setting.
- Cystic fibrosis, other chronic lung disease (except asthma)
- Immunodeficiency or immunosuppressive therapy
- Patients at risk for aspiration pneumonia
- Hospital or institutional-acquired pneumonia